Genitourinary colonization by Streptococcus agalactiae and sensitivity profile in pregnant women
Keywords:
Streptococcus agalactiae, pregnant at term, sensitivity studyAbstract
Introduction: Streptococcus agalactiae, also known as Lancefield’s group B beta-hemolytic streptococcus, acquires relevance during pregnancy due to the possibility of transmission to the newborn. International standards suggest performing vaginal-anal screening between 35 and 37 weeks of gestation.
Objective: to determine the prevalence of colonization by Streptococcus agalactiae, in cervical-vaginal samples of pregnant women between 35 and 37 weeks, and in urine cultures of pregnant women of any gestational age admitted to the provincial gyneco-obstetric hospital, as well as their sensitivity profile.
Materials and methods: an observational, descriptive and exploratory cross-sectional study was performed, between January and August 2021, at the Provincial Teaching Gyneco-obstetric Hospital Jose Ramon Lopez Tabrane of Matanzas. The universe was made up by all pregnant women of any trimester who underwent a urine culture, and a cervical-vaginal microbiologic study between 35 and 37 gestation weeks, previously meeting inclusion criteria.
Results: 18.61% presented positive cultures for Streptococcus agalactiae. The presence of positivity predominated in non-diabetic women. 18.75 % of positive urine cultures were found. Erythromycin and clindamycin-sensitive isolates predominated (MLSBi), with 63%, followed by inducible resistance to clindamycin, with 19%.
Conclusions: the microbiological diagnosis of Streptococcus agalactiae in pregnant women is of vital importance to prevent puerperal and neonatal sepsis. Although the results of this study show adequate sensitivity profiles, its permanent monitoring would warrantee the early diagnosis of resistant strains, given the slight increase of the phenotype (MLSBi) identified.Downloads
References
2. Clouse K, Shehabi A, Suleimat AM, et al. High prevalence of Group B Streptococcus colonization among pregnant women in Amman, Jordan. BMC Pregnancy Childbirth. 2019 [citado 07/10/2021];19(117). Disponible en: https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-019-2317-4#citeas
3. Jara-Rosales S, George-Ortiz V, Rubilar-Reyes B, et al. Tamizaje universal en América para la detección de Streptococcus agalactiae en gestantes: una revisión de la literatura. Mat Actual [Internet]. 2022 [citado 18/05/2023];1(2):1. Disponible en: http://panambi.uv.cl/index.php/matroneria/article/view/3479
4. Shrestha K, Sah AK, Singh N, et al. Molecular Characterization of Streptococcus agalactiae Isolates from Pregnant Women in Kathmandu City. J Trop Med [Internet]. 2020 [citado 07/10/2021];2020:4046703. Disponible en: https://www.hindawi.com/journals/jtm/2020/4046703/
5. Brot C, Menard JP, Bretelle F. Infecciones cervicovaginales durante el embarazo: recomendaciones. EMC - Ginecología-Obstetricia. 2019;55(1):1-11. DOI: 10.1016/S1283-081X(19)41711-6.
6. Chinchilla Ureña AL, Orozco Barquero A, Calvo Arrieta K, et al. Aspectos relevantes de la infección por Streptococcus agalactiae. CS [Internet]. 2021 [citado 18/05/2023];5(3):95-107. Disponible en: https://revistacienciaysalud.ac.cr/ojs/index.php/cienciaysalud/article/view/242
7. Delgado-Arévalo KJ, González-Habib R, Castro-Torres I, et al. Tamizaje del estreptococo del grupo B durante el embarazo: conducta actual en un centro de tercer nivel. Ginecol Obstet Mex [Internet]. 2020 [citado 07/10/2021];88(2):127-9. Disponible en: https://www.scielo.org.mx/scielo.php?pid=S0300-90412020000200127&script=sci_arttext
8. Schrag S, Gorwitz R, Fultz-Butts K, et al. Prevention of perinatal Group B Streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep [Internet]. 2022; 51(RR-11):1-22. Citado en PubMed; PMID: 12211284.
9. Pulido A, Soto J. Incremento de aislamientos de Streptococcus agalactiae en cultivos de orina en un hospital materno-infantil de Lima, Perú. An Fac Med [Internet]. 2019 [citado 07/10/2021];80(2):266-7. Disponible en: http://www.scielo.org.pe/scielo.php?pid=S1025-55832019000200023&script=sci_arttext
10. Coria MP, Guzzetti P, Suárez M, et al. Infecciones urinarias por Streptococcus agalactiae y Staphylococcus saprophyticus y embarazo. Acta Bioquím Clín Latinoam [Internet]. 2018 [citado 07/10/2021];52(4):423-8. Disponible en: http://www.scielo.org.ar/scielo.php?pid=S0325-29572018000400005&script=sci_abstract&tlng=pt
11. Bretaña EG. Recomendación para la prevención, diagnóstico y tratamiento de la infección neonatal por estreptococo hemolítico del grupo B (EGB) [Internet]. Neuquén, Argentina: Subsecretaría de Salud; 2020 [citado 07/10/2021]. Disponible en: https://www.saludneuquen.gob.ar/wp-content/uploads/2020/09/Ministerio-Salud-Neuqu%C3%A9n_Salud-de-la-embarazada-EGB-actualizacion-revisado-2019.pdf
12. Álvarez Cruz A, Toraño Peraza G, Llanes Caballero R. Colonización vaginal/rectal por Streptococcus agalactiae en gestantes de Melena del Sur, Cuba. Rev Cubana Med Trop [Internet]. 2014 [citado 07/10/2021];66(3):415-23. Disponible en: https://revmedtropical.sld.cu/index.php/medtropical/article/view/53/40
13. Armas Fernández A, Toraño Peraza G, Medina Hernández D, et al. Colonización recto/vaginal por Streptococcus agalactiae en gestantes cubanas. Rev Cubana Med Trop [Internet]. 2018 [citado 07/10/2021];70(3):27-37. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=89186
14. Akhlaghi F, Hamedi A, Naderi MN. Comparison of Group B Streptococcal Colonization in the Pregnant Diabetic and Non-Diabetic Women. Acta Med Iran [Internet]. 2009 [citado 07/10/2021];47(2):103-8. Disponible en: https://www.sid.ir/EN/VEWSSID/J_pdf/86520090206.pdf
15. Botelho ACN, Oliveira JG, Damasco AP, et al. Streptococcus agalactiae carriage among pregnant women living in Rio de Janeiro, Brazil, over a period of eight years. PLoS One [Internet]. 2018 [citado 07/10/2021];13(5):e0196925. Disponible en: https://doi.org/10.1371/journal.pone.0196925
Downloads
Published
How to Cite
Issue
Section
License
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.
Guidelines to authors
